Collectively, these results suggest that the downregulated transcription activity of SOX17 in ESCC causes dysregulation of cytoprotective enzymes controlled by NRF2, and thus resulting in CCRT resistance. This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.